Plus: Construction on a big wind project off New York’s coast is back on, after an abrupt about-face by the Trump administration. And Biotech firm Regeneron has agreed to buy 23andMe out of bankruptcy for $256 million dollars. Kate Bullivant hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices